MDA completes sale of Canadarm3 Technology to Axiom Space
The contract is for the delivery of 32 external robotic interfaces for Axiom Space's Axiom Station which is now under construction.
Technology / IIoT
aerospace and defence
sales and marketing
Space Science and Technology
BRAMPTON — MDA Ltd. announced the first commercial sale of its Canadarm3 technology to Axiom Space.
The contract is for the delivery of 32 external robotic interfaces for Axiom Space’s Axiom Station which is now under construction and on schedule to be the world’s first commercial space station in orbit.
MDA offers a full range of space robotics capabilities for multiple missions and applications. The MDA technology destined for Axiom Station includes commercial variants of Canadarm3 interfaces destined for the Artemis Gateway.
“The sale of our Canadarm3 technology to Axiom Space signifies a major shift in the commercial landscape and is a turning point for MDA as we fulfill our vision of bringing a full suite of space robotics products to market,” said Mike Greenley, CEO of MDA in a statement.
“As the global space economy continues to accelerate, there is increasing demand for a wide variety of space robotics designed to fulfill all kinds of objectives – and MDA is uniquely positioned to capitalize on this opportunity. Today’s announcement is just the beginning of this journey, and yet another proof point that MDA can meet the growing needs of space companies around the world.”
The MDA interfaces aboard Axiom’s space station will also include those that allow the existing Canadarm2 on the International Space Station (ISS) to build and assemble the new Axiom Station. Once that stage is complete, MDA’s Canadarm3 interfaces will act as permanent robotic system fixture points on the outside of Axiom Station, forming the foundation for future robotic arm integration and utilization once it separates from the ISS and operates independently.